FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017013636> ?p ?o ?g. }

• W2017013636 endingPage "83" @default.
• W2017013636 startingPage "75" @default.
• W2017013636 abstract "Background and purpose: Maintenance treatments with methadone or buprenorphine are more or less efficient procedures for helping heroin addicts to stop or reduce drug abuse. Another approach to treat opiate dependence could be to target the endogenous opioid system by enhancing the effects of enkephalins by protecting them from enzymic degradation by the dual peptidase inhibitor RB101. Experimental approach: As chronic treatment with the dopamine D2 antagonist amisulpride facilitates RB101‐induced behavioral effects, we chose in this study to treat mice previously sensitized to the hyperlocomotor effects induced by morphine with a combination of amisulpride and RB101. Key results: Expression of morphine‐induced locomotor sensitization was abolished after combined treatment with amisulpride (20 mg.kg −1 , i.p.) and RB101 (80 mg.kg −1 , i.p.), whereas these drugs were not effective when used alone. We then compared these results with the effects of amisulpride combined with buprenorphine (0.1 mg.kg −1 , i.p.) or methadone (2.5 mg.kg −1 , i.p.) upon morphine‐induced behavioral sensitization. Whereas the combination of amisulpride and buprenorphine partially blocked the expression of morphine sensitization, amisulpride+methadone was not effective in this paradigm. Conclusions and implications: The combination of amisulpride+RB101 appears to be very efficient in blocking the expression of morphine‐induced behavioral sensitization. This could reflect a reinstatement of a balance between the function of the dopamine and opioid systems and could represent a new approach in maintenance treatments for opiate addiction. British Journal of Pharmacology (2007) 151 , 75–83. doi: 10.1038/sj.bjp.0707195" @default.
• W2017013636 created "2016-06-24" @default.
• W2017013636 creator A5018112985 @default.
• W2017013636 creator A5032132304 @default.
• W2017013636 creator A5047322375 @default.
• W2017013636 creator A5077955988 @default.
• W2017013636 date "2007-05-01" @default.
• W2017013636 modified "2023-10-18" @default.
• W2017013636 title "Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments" @default.
• W2017013636 cites W147717426 @default.
• W2017013636 cites W1497141468 @default.
• W2017013636 cites W1570717867 @default.
• W2017013636 cites W1784973898 @default.
• W2017013636 cites W1817985333 @default.
• W2017013636 cites W1964024221 @default.
• W2017013636 cites W1979547579 @default.
• W2017013636 cites W1982072195 @default.
• W2017013636 cites W1982648534 @default.
• W2017013636 cites W1983702349 @default.
• W2017013636 cites W1983869923 @default.
• W2017013636 cites W1986075380 @default.
• W2017013636 cites W1997885391 @default.
• W2017013636 cites W2004179925 @default.
• W2017013636 cites W2010906830 @default.
• W2017013636 cites W2023042672 @default.
• W2017013636 cites W2025339047 @default.
• W2017013636 cites W2027647136 @default.
• W2017013636 cites W2027873427 @default.
• W2017013636 cites W2033290021 @default.
• W2017013636 cites W2038370141 @default.
• W2017013636 cites W2041916596 @default.
• W2017013636 cites W2052414707 @default.
• W2017013636 cites W2054107609 @default.
• W2017013636 cites W2057176173 @default.
• W2017013636 cites W2057725940 @default.
• W2017013636 cites W2068950095 @default.
• W2017013636 cites W2075593523 @default.
• W2017013636 cites W2082496702 @default.
• W2017013636 cites W2083071923 @default.
• W2017013636 cites W2094957254 @default.
• W2017013636 cites W2095549579 @default.
• W2017013636 cites W2099576957 @default.
• W2017013636 cites W2114804016 @default.
• W2017013636 cites W2123281693 @default.
• W2017013636 cites W2125350295 @default.
• W2017013636 cites W2141778513 @default.
• W2017013636 cites W2145847623 @default.
• W2017013636 cites W2154237001 @default.
• W2017013636 cites W2154378024 @default.
• W2017013636 cites W2159314582 @default.
• W2017013636 cites W2162049259 @default.
• W2017013636 cites W2260195689 @default.
• W2017013636 cites W2271894037 @default.
• W2017013636 cites W2279819138 @default.
• W2017013636 cites W2465465875 @default.
• W2017013636 cites W35408201 @default.
• W2017013636 cites W4323237693 @default.
• W2017013636 doi "https://doi.org/10.1038/sj.bjp.0707195" @default.
• W2017013636 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2012985" @default.
• W2017013636 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17351659" @default.
• W2017013636 hasPublicationYear "2007" @default.
• W2017013636 type Work @default.
• W2017013636 sameAs 2017013636 @default.
• W2017013636 citedByCount "12" @default.
• W2017013636 countsByYear W20170136362012 @default.
• W2017013636 countsByYear W20170136362013 @default.
• W2017013636 countsByYear W20170136362014 @default.
• W2017013636 countsByYear W20170136362020 @default.
• W2017013636 countsByYear W20170136362021 @default.
• W2017013636 countsByYear W20170136362023 @default.
• W2017013636 crossrefType "journal-article" @default.
• W2017013636 hasAuthorship W2017013636A5018112985 @default.
• W2017013636 hasAuthorship W2017013636A5032132304 @default.
• W2017013636 hasAuthorship W2017013636A5047322375 @default.
• W2017013636 hasAuthorship W2017013636A5077955988 @default.
• W2017013636 hasBestOaLocation W20170136361 @default.
• W2017013636 hasConcept C118552586 @default.
• W2017013636 hasConcept C126322002 @default.
• W2017013636 hasConcept C170493617 @default.
• W2017013636 hasConcept C203014093 @default.
• W2017013636 hasConcept C2776217527 @default.
• W2017013636 hasConcept C2776412080 @default.
• W2017013636 hasConcept C2777389121 @default.
• W2017013636 hasConcept C2778140631 @default.
• W2017013636 hasConcept C2778767360 @default.
• W2017013636 hasConcept C2778949969 @default.
• W2017013636 hasConcept C2778999636 @default.
• W2017013636 hasConcept C2780494398 @default.
• W2017013636 hasConcept C2781063702 @default.
• W2017013636 hasConcept C42219234 @default.
• W2017013636 hasConcept C71924100 @default.
• W2017013636 hasConcept C98274493 @default.
• W2017013636 hasConceptScore W2017013636C118552586 @default.
• W2017013636 hasConceptScore W2017013636C126322002 @default.
• W2017013636 hasConceptScore W2017013636C170493617 @default.
• W2017013636 hasConceptScore W2017013636C203014093 @default.
• W2017013636 hasConceptScore W2017013636C2776217527 @default.
• W2017013636 hasConceptScore W2017013636C2776412080 @default.

• next